Thus, it was deemed plausible that combined aerobic and resistance exercise increased PPARα activity through AMPK/SIRT1 pathways downstream of GCN2 inhibition, enhancing hepatocyte fat oxidation to guard against NAFLD. The gene discussed is EIF2AK4; the disease is metabolic dysfunction-associated steatotic liver disease.